Pathophysiology of Vascular Calcification
- PMID: 26409849
- DOI: 10.1007/s11914-015-0293-9
Pathophysiology of Vascular Calcification
Abstract
Vascular calcification can lead to cardiovascular morbidity and mortality. The initiating factors and clinical consequences depend on the underlying disease state and location of the calcification. The pathogenesis of vascular calcification is complex and involves a transformation of vascular smooth muscle cells to an osteo/chondrocytic cell that expresses RUNX2 and produces matrix vesicles. The imbalance of promoters (such as hyperphosphatemia and hypercalcemia) and inhibitors (e.g., fetuin-A) is critical in the development of vascular calcification. The altered mineral metabolism and deficiency in inhibitors are common in patients with chronic kidney disease (CKD) and is one reason why vascular calcification is so prevalent in that population.
Keywords: Calcification; Vascular calcification; Vascular smooth muscle cells.
Similar articles
-
Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia.Cell Mol Life Sci. 2019 Jun;76(11):2077-2091. doi: 10.1007/s00018-019-03054-z. Epub 2019 Mar 18. Cell Mol Life Sci. 2019. PMID: 30887097 Free PMC article. Review.
-
Key regulators of vascular calcification in chronic kidney disease: Hyperphosphatemia, BMP2, and RUNX2.PeerJ. 2024 Sep 19;12:e18063. doi: 10.7717/peerj.18063. eCollection 2024. PeerJ. 2024. PMID: 39308809 Free PMC article. Review.
-
Induction of intracellular heat-shock protein 72 prevents the development of vascular smooth muscle cell calcification.Cardiovasc Res. 2012 Dec 1;96(3):524-32. doi: 10.1093/cvr/cvs278. Epub 2012 Aug 29. Cardiovasc Res. 2012. PMID: 22933322
-
High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease.Nephrol Dial Transplant. 2019 Jun 1;34(6):934-941. doi: 10.1093/ndt/gfy287. Nephrol Dial Transplant. 2019. PMID: 30189026
-
Vascular calcification in chronic kidney disease: an update.Nephrol Dial Transplant. 2016 Jan;31(1):31-9. doi: 10.1093/ndt/gfv111. Epub 2015 Apr 26. Nephrol Dial Transplant. 2016. PMID: 25916871
Cited by
-
Role of the extracellular ATP/pyrophosphate metabolism cycle in vascular calcification.Purinergic Signal. 2023 Jun;19(2):345-352. doi: 10.1007/s11302-022-09867-1. Epub 2022 May 5. Purinergic Signal. 2023. PMID: 35511317 Free PMC article. Review.
-
Therapeutic Interference With Vascular Calcification-Lessons From Klotho-Hypomorphic Mice and Beyond.Front Endocrinol (Lausanne). 2018 May 4;9:207. doi: 10.3389/fendo.2018.00207. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29780355 Free PMC article. Review.
-
Potential Role of Novel Cardiovascular Biomarkers in Pediatric Patients with Chronic Kidney Disease.Mini Rev Med Chem. 2024;24(5):491-506. doi: 10.2174/1389557523666230523114331. Mini Rev Med Chem. 2024. PMID: 37231748 Review.
-
Elevated glucose levels increase vascular calcification risk by disrupting extracellular pyrophosphate metabolism.Cardiovasc Diabetol. 2024 Nov 11;23(1):405. doi: 10.1186/s12933-024-02502-w. Cardiovasc Diabetol. 2024. PMID: 39529124 Free PMC article.
-
Elevated Levels of Serum Alkaline Phosphatase are Associated with Increased Risk of Cardiovascular Disease: A Prospective Cohort Study.J Atheroscler Thromb. 2023 Jul 1;30(7):795-819. doi: 10.5551/jat.63646. Epub 2022 Oct 19. J Atheroscler Thromb. 2023. PMID: 36261365 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical